GSK has claimed its second breakthrough designation from the FDA for antibody-drug conjugate GSK5764227, which it licensed from China's Hansoh Pharma in a $1.7 billion deal. The status has been ...

GSK confirmed this morning that the disappointing readout from the DREAMM-3 trial of multiple myeloma therapy Blenrep reported earlier this month means that it will take the drug off the US market.

Involves transaction of at least 0.5% of the listed shares of a company. What was Glaxosmithkline Pharmaceuticals Ltd share price previously? Glaxosmithkline Pharmaceuticals Ltd share price was up ...

Vageshwari Properties has purchased a historic bungalow at Malabar Hill in Mumbai for Rs 276 crore. The property, known as Laxmi Nivas, was a secret hideout for freedom fighters during the Quit... Mar ...

3 Year 71.86% 72.10% 32.90% 34.68% ...